First Time Loading...
T

Talis Biomedical Corp
NASDAQ:TLIS

Watchlist Manager
Talis Biomedical Corp
NASDAQ:TLIS
Watchlist
Price: 9.15 USD 0.55% Market Closed
Updated: May 5, 2024

Talis Biomedical Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Talis Biomedical Corp
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
T
Talis Biomedical Corp
NASDAQ:TLIS
Revenue
$4.8m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.7B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$21B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

See Also

What is Talis Biomedical Corp's Revenue?
Revenue
4.8m USD

Based on the financial report for Dec 31, 2022, Talis Biomedical Corp's Revenue amounts to 4.8m USD.

What is Talis Biomedical Corp's Revenue growth rate?
Revenue CAGR 3Y
7%

Over the last year, the Revenue growth was -41%. The average annual Revenue growth rates for Talis Biomedical Corp have been 7% over the past three years .